Practice Considerations News Today

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for hypertensive disorders in pregnant persons with blood pre

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends that clinicians prescribe preexposure prophylaxis using effective antir

This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety disorders in adults, including pregnant and postp

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for depression in the adult population, including pregnant an

This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for LTBI in populations at increased risk (B recommendation).

Faculty member advocates for sleep health training for social workers to better serve clients

This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef

This 2022 Recommendation Statement from the US Preventive Services Task Force recommends against the use of combined estrogen and progestin for the primary prev

The U.S. Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to Statin Use for the Primary Prevention of Cardiovascular Disease in Adults, published in the Journal of American Medical Association (JAMA). This recommendation replaces the 2016 USPSTF recommendation on statin use for the primary prevention of CVD and is generally consistent with that recommendation.